Literature DB >> 9596728

Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells.

T Musso1, L Calosso, M Zucca, M Millesimo, M Puliti, S Bulfone-Paus, C Merlino, D Savoia, R Cavallo, A N Ponzi, R Badolato.   

Abstract

Interleukin-15 (IL-15) is a recently discovered cytokine produced by a wide range of different cell types including fibroblasts, keratinocytes, endothelial cells, and macrophages in response to lipopolysaccharide or microbial infection. This suggests that IL-15 may play a crucial role in the activation of phagocytic cells against pathogens. We studied polymorphonuclear leukocyte (PMN) activation by IL-15, evaluated as enhancement of PMN anti-Candida activity as well as IL-8 production, following stimulation with the cytokine. The PMN response to IL-15 depends on binding to the IL-15 receptor. Our experiments show that binding of a biotinylated human IL-15-immunoglobulin G2b IgG2b fusion protein was competed by the addition of human recombinant IL-15 (rIL-15) or of human rIL-2, suggesting that IL-15 binding to PMN might involve the IL-2Rbeta and IL-2Rgamma chains, which have been shown to be constitutively expressed by PMN. In addition, we show by reverse transcription-PCR and by flow cytometry with a specific anti-IL-15Ralpha chain monoclonal antibody that PMN express the IL-15Ralpha chain at the mRNA and protein levels. Incubation with IL-15 activated PMN to secrete the chemotactic factor IL-8, and the amount secreted was increased by costimulation with heat-inactivated Candida albicans. In addition, IL-15 primed the metabolic burst of PMN in response to formyl-methionyl-leucyl-phenylalanine but was not sufficient to trigger the respiratory burst or to increase the production of superoxide in PMN exposed to C. albicans. IL-15 also increased the ability of PMN to phagocytose heat-killed C. albicans organisms in a dose-dependent manner, without opsonization by antibodies or complement-derived products. In the same concentration range, IL-15 was as effective as gamma interferon (IFN-gamma) and IL-2 in increasing the C. albicans growth-inhibitory activity of PMN. Taken together, these results suggest that IL-15 is a potent stimulant of both proinflammatory and antifungal activities of PMN, activating several antimicrobial functions of PMN involved in the cellular response against C. albicans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596728      PMCID: PMC108250          DOI: 10.1128/IAI.66.6.2640-2647.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes.

Authors:  R Badolato; A N Ponzi; M Millesimo; L D Notarangelo; T Musso
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

Review 2.  Granules of the human neutrophilic polymorphonuclear leukocyte.

Authors:  N Borregaard; J B Cowland
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

3.  Bacterial infection induces nitric oxide synthase in human neutrophils.

Authors:  M A Wheeler; S D Smith; G García-Cardeña; C F Nathan; R M Weiss; W C Sessa
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells.

Authors:  F Malavasi; F Caligaris-Cappio; C Milanese; P Dellabona; P Richiardi; A O Carbonara
Journal:  Hum Immunol       Date:  1984-01       Impact factor: 2.850

5.  Differential regulation of human T lymphoblast functions by IL-2 and IL-15.

Authors:  S Bulfone-Paus; H Dürkop; R Paus; H Krause; T Pohl; A Onu
Journal:  Cytokine       Date:  1997-07       Impact factor: 3.861

6.  Interleukin-15 protects from lethal apoptosis in vivo.

Authors:  S Bulfone-Paus; D Ungureanu; T Pohl; G Lindner; R Paus; R Rückert; H Krause; U Kunzendorf
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

7.  Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans.

Authors:  N Vázquez; T J Walsh; D Friedman; S J Chanock; C A Lyman
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

8.  Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.

Authors:  M S Cohen; R E Isturiz; H L Malech; R K Root; C M Wilfert; L Gutman; R H Buckley
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

9.  Expression of interleukin-2 receptor gamma chain on human neutrophils.

Authors:  J H Liu; S Wei; D Ussery; P K Epling-Burnette; W J Leonard; J Y Djeu
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

10.  Induction of germ tube formation by N-acetyl-D-glucosamine in Candida albicans: uptake of inducer and germinative response.

Authors:  E Mattia; G Carruba; L Angiolella; A Cassone
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

View more
  13 in total

1.  Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques.

Authors:  Maren Q DeGottardi; Afam A Okoye; Mukta Vaidya; Aarthi Talla; Audrie L Konfe; Matthew D Reyes; Joseph A Clock; Derick M Duell; Alfred W Legasse; Amit Sabnis; Byung S Park; Michael K Axthelm; Jacob D Estes; Keith A Reiman; Rafick-Pierre Sekaly; Louis J Picker
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

2.  Interleukin-15 increases neutrophil adhesion onto human respiratory epithelial A549 cells and attracts neutrophils in vivo.

Authors:  M Pelletier; D Girard
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes.

Authors:  N L Mathy; W Scheuer; M Lanzendörfer; K Honold; D Ambrosius; S Norley; R Kurth
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

Review 4.  Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.

Authors:  Jamel El-Benna; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo
Journal:  Semin Immunopathol       Date:  2008-06-07       Impact factor: 9.623

5.  Host's innate immune response to fungal and bacterial agents in vitro: up-regulation of interleukin-15 gene expression resulting in enhanced natural killer cell activity.

Authors:  Phay Tran; Rasheed Ahmad; Jingwu Xu; Ali Ahmad; José Menezes
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

6.  Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.

Authors:  Louise S Villadsen; Janine Schuurman; Frank Beurskens; Tomas N Dam; Frederik Dagnaes-Hansen; Lone Skov; Jorgen Rygaard; Marleen M Voorhorst-Ogink; Arnout F Gerritsen; Marc A van Dijk; Paul W H I Parren; Ole Baadsgaard; Jan G J van de Winkel
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 7.  Neutrophil cell surface receptors and their intracellular signal transduction pathways.

Authors:  Krisztina Futosi; Szabina Fodor; Attila Mócsai
Journal:  Int Immunopharmacol       Date:  2013-08-30       Impact factor: 4.932

8.  An activation-induced IL-15 isoform is a natural antagonist for IL-15 function.

Authors:  Lei Zhao; Bo Hu; Yinsheng Zhang; Yuan Song; Dandan Lin; Yonghao Liu; Yu Mei; Dedy Sandikin; Weiping Sun; Min Zhuang; Haiyan Liu
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

Review 9.  Multiple Phenotypic Changes Define Neutrophil Priming.

Authors:  Irina Miralda; Silvia M Uriarte; Kenneth R McLeish
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

10.  Modeling the pharmacokinetic-pharmacodynamic relationship of the monoclonal anti-macaque-IL-15 antibody Hu714MuXHu in cynomolgus monkeys.

Authors:  Wei J Pan; Hong Li; Jim J Xiao; Michelle J Horner; Herve N Lebrec; Eric A Butz; Arunan Kaliyaperumal; Tsui C Cheah; Robert C Ortiz; Samantha P Prokop; Sabina A Buntich; Babette M Boren; Suzanne T Wolford; Wayne H Tsuji; Larry C Wienkers; Kathleen Köck
Journal:  Pharmacol Res Perspect       Date:  2016-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.